Novellia Launches Project EVOLVE, Digital Registry Platform to Transform HER2+ Breast Cancer Care
NEW YORK, NY, August 7, 2023 - Novellia, Inc., an AI-enabled health data company harnessing the power of personal healthcare to drive precision medicine forward, announces the launch of Project EVOLVE using its custom digital registry solution for tracking real-world outcomes in HER2+ breast cancer treatment. Project EVOLVE, funded by global biopharmaceutical leaders Daiichi Sankyo and AstraZeneca, demonstrates Novellia's ability to deliver scalable, AI-powered insights from fragmented patient data unified across healthcare systems.
This implementation of Novellia's custom digital registry solution will enable comprehensive tracking of patient outcomes and treatment patterns, with an initial focus on interstitial lung disease (ILD) monitoring in HER2+ breast cancer patients. The technology rapidly aggregates and analyzes longitudinal medical histories across healthcare systems, providing biopharmaceutical companies with actionable insights that were previously impossible to obtain at scale.
"This research showcases how Novellia's standardized approach to unifying fragmented health data can be rapidly deployed across any therapeutic area to generate valuable real-world insights," said Shashi Shankar, CEO of Novellia. "Our custom digital registry solution eliminates the traditional barriers of manual data collection and fragmented records, offering life sciences companies a repeatable, scalable way to understand treatment outcomes and optimize patient care."
The registry launched in August 2023 in collaboration with PRIME Education, demonstrating Novellia's ability to seamlessly integrate with existing healthcare infrastructure to provide tailored educational interventions informed by insights from Novellia's data analysis. Results from this research will be presented at a future medical conference, and the outcomes will aim to provide critical insights that could shape the future of HER2+ breast cancer treatment and potentially improve outcomes for patients.
